August 13, 2009 – Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed to evaluate the safety and effectiveness of the company's XIENCE V Everolimus-Eluting Coronary Stent System in a real-world clinical setting out to five years.

August, 13, 2009 – Atherotech Inc. this week added two new cardiometabolic tests – the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early, sensitive marker for chronic kidney disease.

August 13, 2009 – The pharmaceutical and healthcare research firm Decision Resources found Merck/Schering-Plough's Zetia and Vytorin lost substantial patient share in second- and third-line therapy since last.

August 13, 2009 – Data published today in the Journal of the American College of Cardiology (JACC) indicates percutaneous valve repair with the MitraClip therapy can reduce acute mitral regurgitation (MR) with sustained freedom from death, surgery or recurrent MR in a substantial proportion of functional and degenerative MR patients.

August 12, 2009 - The Food and Drug Administration's (FDA) top medical-device regulator, Daniel Schultz, M.D., director of the FDA Center for Devices and Radiological Health, announced his resignation.

August 12, 2009 – The Cardiovascular Research Foundation announced today the late breaking trials that will be presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009 symposium Sept. 21-25 in San Francisco.

August 12, 2009 – Abiomed Inc. said a webcast of an Impella 2.5 procedure performed on an 85-year-old man with multivessel disease at Mount Sinai Medical Center, now available and archived on the Abiomed Web site www.abiomed.com.

August 12, 2009 – Researchers at the Georgia Institute of Technology, collaborating with pediatric cardiologists and surgeons at The Children's Hospital of Philadelphia, have developed a tool for virtual surgery that allows heart surgeons to view the predicted effects of different surgical approaches by manipulating 3D cardiac MRIs of a patient's specific anatomy.

August 11, 2009 – Pathway Medical Technologies Inc. today introduced the 7 French compatible version of its peripheral atherectomy catheter, the Jetstream G2 NXT.

August 11, 2009 – Physicians in the United Kingdom yesterday completed patient implants using the first CE mark approved drug-eluting stent designed specifically to treat severe peripheral artery disease (PAD) blockages in the challenging and largest artery in the leg.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now